VP 16 carboplatinum in neuroblastoma: a SFOP phase II study. The Société Française d'Oncologie Pédiatrique.

Frappaz, D; Michon, J; Hartmann, O; Bouffet, E; Gentet, J C; Chastagner, P; Sariban, E; Brugière, L; Rubie, H; Lejars, O

Frappaz, D; Michon, J; Hartmann, O; Bouffet, E; Gentet, J C; Chastagner, P; Sariban, E; Brugière, L; Rubie, H; Lejars, O.

Affiliation

Frappaz D; Centre L. Bérard, Lyon, France.

Prog Clin Biol Res ; 366: 561-6, 1991.

Article in En | MEDLINE | ID: mdl-2068174

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/toxicity; Carboplatin/toxicity; Etoposide/toxicity; Neuroblastoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carboplatin/administration & dosage; Child, Preschool; Drug Evaluation; Etoposide/administration & dosage; Female; Humans; Male; Neoplasm Staging; Neuroblastoma/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carboplatin / Etoposide / Neuroblastoma Limits: Child, preschool / Female / Humans / Male Language: En Journal: Prog Clin Biol Res Year: 1991 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links